Three extraction methods were sequentially combined to obtain fractions from Lentinula edodes (shiitake mushrooms) containing bioactive compounds against cardiovascular diseases (CVDs). Fruiting bodies were first extracted with plain water, obtained residue was then submitted to supercritical fluid extraction (SFE) and remaining residue submitted to hot water extraction. Sequential design allowed reutilization of the nonextracted material as raw material for the successive extractions increasing extraction yields and separating interesting compounds. Obtained fractions contained different amounts of ß-glucans, chitins, eritadenine, lenthionine, ergosterol, proteins/peptides and phenolic compounds conferring them different bioactivities. Water soluble fractions showed high antioxidant activities (ABTS
may be designed if all compounds are combined and, besides those inhibiting cholesterol absorption, other compounds are incorporated such as those reducing the risk of CVDs by different mechanisms of action. 4 Edible mushrooms are natural sources of hypocholesterolemic compounds, such as fungal sterols (ergosterol and derivatives) and polysaccharides (b-glucans, chitins, etc.) that according to in vitro experiments might inhibit cholesterol absorption and biosynthesis. [4] [5] [6] [7] Eritadenine (2(R),3(R)-dihydroxy-4-(9-adenyl) butanoic acid) from Lentinula edodes (shiitake mushrooms) was also able to lower cholesterol levels by acting as an inhibitor of the S-adenosyl-Lhomocysteine hydrolase involved in the hepatic phospholipid metabolism. 8, 9 When lard was supplemented with extracts containing these compounds and fed to mice, they succeeded to avoid the increasing of cholesterol levels noticed in control mice fed only with lard. 10 Moreover, water extracts obtained from edible mushrooms such as Hypsizygus marmoreus and Lactarius camphorates were also able to inhibit ACE because of their hypotensive peptides 11, 12 and lenthionine (1,2,3,5,6-pentahiepane), an organosulfur compound responsible for the characteristic flavor of shiitake mushrooms, inhibited platelet aggregation. 13 Water and hot water extracts from other mushroom species also showed interesting antioxidant activities that correlated to their levels of ergothioneine and phenolic compounds. [14] [15] [16] Several methods to isolate or extract each type of those previously mentioned compounds have been already reported. Different b-glucans types are usually isolated by alkali/acid treatments, hot water (1208C, 20 min), microwave, pressurized solvent, or ultrasound assisted extractions, [17] [18] [19] chitins needed more drastic treatments, 20 and sterols were isolated using mixtures of organic solvents or supercritical CO 2 extractions. 21 However, all these methods were optimized to use mushrooms as raw material and for each extraction, a new batch of powdered mushrooms should be used. In this work, a sequential extraction method was designed to extract from the same batch of mushroom powder a few fractions enriched in different bioactive compounds against CVDs. The residue remaining after one extraction was used to extract other compounds at the following extraction step instead of using different batches of mushroom powder for each type of compound.
Materials and Methods

Biological material
Dry Lentinula edodes S. (Berkeley) mushrooms were obtained in a local market (Madrid, Spain). Fruiting bodies were ground as a whole or divided into caps and stipes until a fine powder was obtained and stored at 2208C as indicated by Ramirez-Anguiano et al., 2007 16 (they were used to analyze separated tissues). Larger amounts of powdered shiitake mushrooms were also purchased from Glucanfeed S.L. (La Rioja, Spain). Obtained powder showed a particle size lower than 0.5 mm, and moisture content lower than 5% and it was stored in darkness at 2208C until further use.
Reagents
Solvents as hexane (95%), chloroform (HPLC grade), methanol (HLPC grade), acetonitrile (HPLC grade) were obtained from LAB-SCAN (Gliwice, Polland) and absolute ethanol, sodium carbonate (Na 2 CO 3 ) and sulfuric acid (H 2 SO 4 ) from Panreac (Barcelona, Spain). Potassium hydroxide (KOH), ascorbic acid, 2,6-Di-tert-butyl-p-cresol (BHT), bovine serum albumin (BSA), acetylacetone, pdimethylaminebenzaldehyde, Trizma base, HCl (37%), trifluoroacetic acid (99%), phenol, Folin Ciocalteu's phenol reagent, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), potassium persulfate, Angiotensin-I Converting Enzyme (ACE) (5 UN/mL), zinc chloride (ZnCl 2 ) solution (0.1 M) as well as hexadecane, ergosterol (95%), Dglucose, D-glucosamine hydrochloride, gallic acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), sodium phosphate monobasic dihydrate (NaH 2 PO 4 Á 2H 2 O), sodium phosphate dibasic anhydre (Na 2 HPO 4 ), potassium ferrycianide (K 3 [Fe(CN) 6 )], ferric chloride (FeCl 3 ) and Trolox were purchased from Sigma-Aldrich Quimica (Madrid, Spain). CO 2 was supplied by Air-Liquid, S.A. (Madrid, Spain). D-Eritadenine (90%) was acquired from Sy Synchem UG & Co. KG (Felsberg, Germany), lenthionine (80%) from Cymit (Barcelona, Spain) and N-(2-aminobenzoyl)glycil-4-nitro-l-phenylanalyl-l-proline (Abz-Gly-Phe(NO 2 )-Pro) from Bachem Feinchemikalien (Bubendorf, Switzerland). All other reagents and solvents were used of analytical grade.
Sequential extractions
A method to obtain different bioactive fractions from powdered shiitake mushrooms was optimized based on three successive extractions (Figure 1 ). First (Step A), mushroom powder was mixed with water (50 g/L) at room temperature (RT) and vigorously stirred during 1 minute. Afterwards, the mixture was centrifuged (7 min, 7,000 rpm, 108C) in a Heraus Multifuge 3SR1 centrifuge (Thermo Fisher Scientific, Madrid, Spain). Obtained supernatant (considered extract ExA) was separated from the residue (ReA) and both fractions were freeze dried in a LyoBeta 15 lyophilizer (Telstar, Madrid, Spain). Second (Step B), freeze-dried ReA (253 g) was ground, sieved until particles size < 0.5 mm and submitted to supercritical fluid extraction (SFE). ReA was mixed with 1.9 kg of 5 mm diameter stainless steel spheres (a ratio 1:1 (v/v) extract:spheres) in a 2 L extraction cell connected to a SFE pilot-scale plant (model SF2000, TharTechnology, Pittsburgh, PA). Pressurized CO 2 was forced to reach supercritical state and injected in the loaded extraction cell. Extracted material was collected in two different separators (S1 and S2) each of 0.5 L capacity with independent control of temperature and pressure. The extraction vessel had a ratio of 5.5 height/diameter (a detailed explanation of the experimental device can be found at Garcia-Risco et al., 2011 22 ). Extraction was carried out at 35 MPa and 408C. Pressure of S1 and S2 was maintained at 10 and 6 MPa, respectively, and temperature in both of them was 408C. The CO 2 flow was set at 3.6 kg/h and during the total extraction time (3 h) and it was recirculated. Extracted compounds were precipitated in both separators and at the end of the extraction process, the fractions were dragged with ethanol and immediately submitted to concentration until dryness on a rotary vacuum evaporator. Dried extract (ExB) was stored at 2208C until further analysis and nonextracted residual material (ReB) was separated from steel spheres by sieving.
Finally (Step C), ReB (100 g/L) was submitted to hot water extraction (988C) in a 0.5 L flask during 1 h under vigorous stirring and reflux using a glass steam condenser.
The soluble (ExC) and nonsoluble (ReC) fractions were separated by centrifugation (7 min, 7,000 rpm, 108C) and freeze dried.
Carbohydrates determinations
The total carbohydrate content of shiitake mushroom samples or obtained extracts was determined by the phenolsulphuric acid method adapted from Dubois et al. (1956) . 23 Briefly, samples (1 mg) were mixed with 1 mL of MilliQ water and stirred during 2 min. The mixtures (25 mL) were added to a 96-well plate, plus 25 mL of 5% phenol solution (w/v) and 125 mL of concentrated H 2 SO 4 . Afterwards, the plate was sealed and incubated in a water bath at 808C for 30 min. Samples absorbance was read using a M200 Plate Reader (Tecan, Mannedorf, Switzerland) at 595 nm. A standard curve of D-glucose (0.032-0.8 mg/mL) was used for quantification.
Chitin content was determined according to Smiderle et al. (2017) . 18 First, samples were hydrolyzed with 6 M HCl at 1008C for 2 h and adjusted to pH 10.0 after cooling down. Then, hydrolyzed samples (250 mL) were treated as described by Rementeria et al. (1991) . 24 Samples absorbance was measured at 530 nm using an Evolution 600 UV-vis (Thermo Fisher Scientific, Spain) spectrophotometer. A glucosamine hydrochloride standard curve was used for quantification.
The b-glucan content of the obtained mushroom samples and extracts (50 mg) was evaluated by a b-glucan determination kit specific for mushrooms and yeasts (MegazymeV R , Biocom, Barcelona, Spain) following the instructions of the user s manual.
Total phenol content and proteins or peptides determination
The total phenol concentration of samples (10 mg) was determined by the Folin-Ciocalteu method according to the procedure of Ramirez-Anguiano et al. (2007) . 16 Gallic acid was used as standard for quantification.
The total protein concentration of the samples (10 mg/mL) was determined using the Bradford method reagents (SigmaAldrich, Madrid, Spain) according to the Instruction Manual. To determine the amount of peptides, extracts were solubilized in water (100 mg/mL) and submitted to centrifugation (14,000 rpm, 30 min) using Amicon Ultra filter devices with Ultracel 3K membrane (Millipore, Billerica) obtaining a filtrate (< 3 kDa) and a concentrate (> 3 kDa). The latter fraction was submitted to a second centrifugation (14,000 rpm, 20 min) using Nanosep centrifugal device with Omega 10 K membrane (Pall Life Sciences, New York), obtaining a filtrate (fraction with MW between 3 and 10 kDa) and a concentrate (> 10 kDa). The obtained fractions were freeze dried and mixed with the Bradford reagent as described above. BSA was used as standard (0.0125-0.5 mg/mL) for protein quantification.
Eritadenine and lenthionine determination by HPLC-DAD
Eritadenine was extracted from the samples and analyzed following the procedure of Afrin et al. (2016) 25 with modifications. Briefly, samples (1 g) were mixed with 10 mL of 60% ethanol (v/v) and stirred for 2 min. The mixture was centrifugated (15 min, 7,000 rpm, 108C) and the supernatant was collected. Afterwards, 10 mL of 60% ethanol (v/v) was added for a second extraction and both supernatants were pooled together and submitted to vacuum filtration. The filtrate was concentrated on a rotary vacuum extractor at 608C until dryness. Identification and quantification of eritadenine were carried out using a C18 Spherisorb ODS2 4 3 250 mm analytical column with a 5 mm particle size (Waters, Missisagua, Ontario, Canada) coupled to an HPLC system (ProStar 330, Varian, Madrid, Spain) with PDA detector (ProStar 363 module, Varian, Madrid, Spain). Samples were dissolved in mobile phase (5 mg/mL) and they were injected (10 mL) and developed under a constant flow (0.5 mL/min) Figure 1 . Outline of the sequential extraction method utilized to obtain different extracts from shiitake mushrooms.
and an isocratic mobile phase of water:acetonitrile (98:2, v/v 1% TFA). Eritadenine was quantified at 260 nm using a commercial standard. The compound eluted at 11.6 min and showed the characteristic eritadenine UV-spectrum.
Lenthionine determination was carried out according to the procedure of Hiraide et al. (2010) 26 with slight modifications. Basically, samples (50 mg) were mixed with 1 mL of 0.2 M Tris-HCl buffer (pH 8.0) and stirred for 1 h. Afterwards, methanol (0.5 mL) was added, stirred for 2 min and centrifuged (14,000 rpm 5 min). The obtained supernatant was collected and the residue submitted to extraction twice. Supernatants were pooled together, diluted with 2.5 mL MilliQ water and filtered using a syringe through a 0.45 mm pore size filter. The filtrate was applied to an ODS cartridge (Waters, Missisagua, Ontario, Canada) preactivated with methanol following manufacturer s instructions. The cartridge was washed with 1 mL 30% methanol (v/v) and lenthionine was eluted with 1 mL 65% methanol (v/v). Obtained eluate (50 mL) was injected into an HPLC-DAD system (the same column and equipment than above described) and developed using an isocratic mobile phase (65% methanol v/v), a constant flow (0.7 mL/min) and temperature (458C). Lenthionine (retention time 10.4 min) was quantified at 230 nm and identified using a lenthionine commercial standard.
Ergosterol determination by GC-MS-FID
Fungal sterols from samples were evaluated following the procedure described by Gil-Ramirez et al. (2013) . 21 The unsaponified fractions obtained (6 mg/mL) were injected into an Agilent HP-5ms capillary column (30 m 3 0.25 mm i.d. and 0.25 mm phase thickness). The column was connected to a 7890A System gas chromatograph (Agilent Technologies, Santa Clara, CA), comprising a split/splitless injector, an electronic pressure control, a G4513A autoinjector, a 5975C triple-axis mass spectrometer detector and a GC-MS Solution software. The injector and detector conditions as well as the column temperature program were those described by GilRamirez et al. (2013) . 21 Ergosterol was used as standard and hexadecane (10% v/v) as internal standard for quantification.
Antioxidant activities
Mushroom powder and obtained extracts were dissolved in water (0.02-0.5 mg/mL) and assayed for their ABTS 1• scavenging activity assay. ABTS radical was chemically generated using potassium persulfate and ABTS 1• scavenging activity was analyzed spectrophotometrically according to Re et al. (1999) , 27 measuring changes in absorbance (734 nm) at several concentrations after 15 min of incubation at room temperature in darkness. Similarly, samples were also dissolved in methanol (0.02-0.5 mg/mL) and mixed with DPPH
• (76 mM) to determine their scavenging capacity according to Mau et al. (2001) . 28 Absorbance at 517 nm was recorded at several concentrations after 15 min incubation at room temperature in darkness. For both radicals the IC 50 was established using the linear correlation obtained with increasing sample concentrations and compared with Trolox to express the results as their TEAC values (trolox equivalent antioxidant capacity).
The ferric ion reducing power of the extracts was evaluated according to the method of Oyaizu (1986) . 29 Samples were dissolved in 200 mM sodium phosphate buffer (0.1-10 mg/mL) and treated as described by Mau et al. (2005) . 30 Absorbance increase was recorded at 700 nm using several concentrations to estimate their EC 50 . Afterwards, it was expressed as TEAC values to be able to compare with the other antioxidant activities.
HMGCR inhibitory activity
The obtained extracts were solubilized in water, ethanol:-water (1:4) or assay buffer (50 mg/mL) and applied (20 mL) into a 96-wells plate. Their inhibitory activity was measured using the commercial HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) activity assay (Sigma-Aldrich, Madrid, Spain) according to the manufacturer's instructions by monitoring their absorbance change (340 nm) at 378C using a 96-wells microplate reader BioTek Sinergy HT (BioTek, Winooski). Pravastatin was utilized as a control for positive inhibition.
ACE inhibitory activity
The Angiotensin-I Converting Enzyme (ACE) inhibitory activity of the obtained extracts was evaluated using the fluorimetric method described by Sentandreu and Toldra (2006) 31 with slight modifications. Basically, 40 mL of different samples dilutions were added to a 96-wells plate, followed by addition of 160 mL of Abz-Gly-Phe(NO 2 )-Pro (0.45 mM) and 40 mL of ACE working solution (0.04 U/ mL). The plate was incubated during 1 h at 378C measuring the generated fluorescence with excitation and emission wavelengths, respectively, 355 and 405 nm. Milli Q water was utilized as a control for negative inhibition.
Statistical analysis
Differences were evaluated at a 95% confidence level (P 0.05) using a one-way analysis of variance (ANOVA) followed by Tukey's Multiple Comparison test. Statistical analysis was performed using GraphPad Prism version 5.01 (GraphPad Software, San Diego, CA). Correlation between different variables was evaluated by computing Pearson correlation coefficient and determination coefficient (P 0.05).
Results and Discussion
Selection of the starting material
The distribution of compounds with beneficial activities against CVDs within the Lentinula edodes fruiting body was investigated as a preliminary study to elucidate whether it was more convenient to use the complete mushroom or perhaps only caps or stipes as raw material for the extractions. However, when the amount of the main bioactive compounds was determined (Table 1) , no significant differences were noticed between tissues. They contained approximately 40% (w/w) carbohydrates and most of them were b-glucans since chitins were found in lower concentrations. Ergosterol and the other bioactive compounds showed levels similar to previous studies 16, 25, 32 being lenthionine the compound found in the lowest concentration (0.15 mg/g) but also similar to other publications. 13, 26 The lower part of L. edodes stipes (the one is in contact with the cultivation substrate) is considered as a by-product and it is usually discarded during harvesting and not commercialized. However, the stipes showed similar concentrations than the complete fruiting body not only of the bioactive molecules but also of other nutrients such as proteins or carbohydrates. This observation indicated that the wasted stipes could be used as source of bioactive compounds as well as the complete fruiting bodies being an alternative for valorization of these wastes. Nevertheless, since the fruiting bodies were more easily available in larger concentrations the following experiments were carried out using the complete mushrooms.
Sequential extraction yields
The sequential extraction method was designed to optimize the use of shiitake mushrooms or their by-products (as they showed similar composition) as material to extract bioactive compounds. The idea was to consecutively use the residue of one extraction to carry out the next one to maximize the number of compounds that could be selectively isolated in each step avoiding the use of larger amounts of mushroom powder for independent extractions.
Water extraction (at room temperature) was selected as first extraction step because some of the bioactive compounds that could be solubilized in this medium were not thermostable (see later for details). Then, the lipid fraction could be extracted with SFE using moderate temperatures (as second step) and in the third step hot water could be used to extract heat resistant molecules such as dietary fibers improving the intestinal bioavailability (for specific b-glucans) and making them more accessible for colonic microbiota. 33, 34 With the first extraction, water extracted 37 g from 100 g (w/w) of the mushroom powder (Figure 2 ). This method was previously used to obtain water-soluble polysaccharides 35 and other compounds of lower molecular weight. 36 The lowest yield (1.1%) was obtained with supercritical CO 2 extraction of the generated residue (1.7% of ReA) since it mostly extracted lipophilic compounds (ExB) and mushrooms have a low lipid content. Moreover, supercritical CO 2 exhibit a high selectivity enabling high recoveries of specific fatty acids, sterols and derivatives from fungal or other matrices. 37 Nevertheless, the obtained yield was similar to those described in previous publications where SFE extractions were carried out directly from fruiting bodies 38, 39 indicating that SFE extractions could be also carried out using the residues obtained after the first extraction step. The last step, a hot water extraction (988C), generated a fraction (ExC) containing 20% (w/w) of ReB (12% of the initial mushroom powder) leaving still a large insoluble fraction (ReC) encompassing 49.5% of the starting material. This procedure is usually utilized to extract certain polysaccharides from the rest of nonsoluble dietary fibres that remain in the residual fraction.
40,41
Distribution of bioactive compounds within the obtained fractions
The levels of the different fungal polysaccharides were evaluated in all the obtained fractions. Results indicated that the water insoluble fractions contained higher levels of total carbohydrates, b-glucans and chitins than water-soluble or SFE fractions (Figure 3a) . The mushroom powder contained 40.7% (w/w) total carbohydrates where 29.3% of them were b-glucans and 6.0% chitins suggesting that the remaining low percentage ($ 5%) should include oligosaccharides, sugars and perhaps small amounts of a-glucans or other heterosaccharides. Total carbohydrates values were in concordance with the literature. 42 b-glucans and chitins were slightly higher than some reports 43, 44 but in the same range than others. [45] [46] [47] Differences might be due to the different methodologies utilized for their determination.
The water extract (ExA) contained a lower content of total carbohydrates and more than half of them were probably sugars and oligomers since they are easily solubilized in water and their b-glucan content was also lower than in the mushroom powder (10.8%). Although in low amounts, chitins were also detected but they might be degradation products or low molecular weight derivatives from chitins since the latter compounds are completely insoluble in water. These derivatives were also noticed in other reports 17, 20 and they might be involved, together with the water soluble bglucans, in the interesting biological activities noticed in mushroom water extracts. Water soluble b-glucans, a-glucans and fucomannogalactans were pointed as compounds potentially involved in the HMG-CoA reductase inhibitory activity noticed in vitro for water soluble extracts. 36 Moreover, chitin oligomers (water-soluble low molecular weight chitin (LMWC) and chitooligosaccharides (COs) derivatives) could be involved in the hypocholesterolemic properties noticed for these extracts. 48 ReA and ReB showed a very similar carbohydrates profile including approximately 39-40% ß-glucans and 7-8% chitins indicating that the supercritical CO 2 extraction did not significantly influenced the polysaccharide composition of the residue obtained after water extraction and none of them was extracted. Alkaline/acid or hot water extractions are usually required to achieve fractions with high polysaccharides yields. 35 The hot water extraction did not succeed to separate b-glucans from chitins. The b-glucans extracted with hot water accounted for approx. less than half of the total carbohydrates noticed in ExC. As probably most of the oligosaccharides and monosaccharides were previously extracted in the ExA, the rest of carbohydrate content could be due to aglucans or other heteropolysaccharides characteristic from L. edodes that were also extracted. Shiitake b-glucans such as lentinan, are usually isolated using hot water extractions although their yields could be enhanced if alkaline media are used. However, alkalis were not recommended since they interfere with the lentinan 3D structure, essential for its biological activities. 49 Hot water soluble polysaccharides were suggested to decrease the oxidative damage related to hypercholesterolemia and modulating immune system. [50] [51] [52] Furthermore, approximately 2/3 of the carbohydrates present in the residue ReC were b-glucans, and chitins (10.2% w/w) that remained being part of the insoluble fractions. They were not extracted neither with cold/hot water or supercritical CO 2 since their concentrations in all the analyzed residues were almost the same. Their complex-forming capacity and polymeric structure are responsible for their extremely low solubility in many simple solvents. 53 However, this characteristic confers them the ability to act as dietary fibres remaining undigested in the intestine and acting on the colonic flora as prebiotic or as hypocholesterolemic fibers. 48, 54 The total protein content measured in shiitake mushroom was in the range of previously reported studies since they might change from approximately 13 to 23% depending on the cultivation conditions, developmental stage or commercial strain. [55] [56] [57] The highest protein content (Figure 3a ) was obtained in ExA, indicating that a considerable amount of Shiitake proteins might be easily extracted with cold water, probably because free proteins, peptides and amino acid derivatives are included in this fraction. Indeed, in this fraction higher amounts of small proteins and peptides (8.57 mg/ g) (with molecular weight (MW) between 10 and 3 kDa) than larger proteins (5.88 mg/g) (MW > 10 kDa) were noticed. It also contained a low amount of peptides and Ncontaining compounds with MW < 3kDa (0.83 mg/g). But, proteins might be also bound to polysaccharides as glycoproteins or proteoglucans impairing their extraction, therefore, other proteins were found in the residues. The high pressure (and/or mild temperature) utilized during SFE extraction seemed to partially denature proteins since ReB protein levels were not the sum of those noticed in the fractions from the following extraction step (Table 2) . Nevertheless, the ExC obtained still contained high protein levels and only low amounts remained in ReC (Figure 3a) suggesting that hot water enhanced extraction of many more proteins or different ones from those found in ExA. Nevertheless, the temperature selected might have also influenced proteins structure generating breaking down products from large Levels of (a) total carbohydrates, b-glucans, chitins, and proteins, (b) eritadenine and lenthionine, and (c) ergosterol and total phenolic compounds. Different letters (a-f) showed statistical significance (P 0.05) between different samples for the same compound.
(5.4 mg/g MW > 10 kDa) and smaller proteins particularly those with MW between 10 and 3 kDa since the ExC contained lower content (1.84 mg/g) than ExA and the fraction with lower MW contained more peptides (1.74 mg/g MW <3 kDa).
Eritadenine is a water-soluble alkaloid, therefore, it was mainly extracted with cold water when compared with the amount noticed in the mushroom powder ( Table 2 ). The minimal amount that remained in the residues was then almost completely extracted with hot water. These results also suggested that eritadenine was resistant to high temperatures and its extraction yield could be enhanced by increasing the extraction temperature. Eritadenine was 2.2-folds more concentrated in the ExA than in the shiitake powder (Figure 3b ), amounts that were only slightly lower than those described in other studies obtained with more complex extraction procedures. 25, 58 Lenthionine was detected in shiitake powder at similar levels than previously reported. 13, 26 It was also noticed in higher concentrations in the ExA extracts (Figure 3b) . Afterwards, only traces remained in ReA but probably the slight increase of temperature together with the high pressure utilized for SFE extraction was sufficient to degrade it being undetected in the following extracted fractions. Lenthionine levels were drastically reduced when extraction temperature was higher than 808C. 59, 60 Thus, apparently pressurized extractions made the compound more susceptible to degradation.
Ergosterol was mainly extracted with SFE (Table 2 ) obtaining a highly concentrated ExB extract (88.7 mg/g) (Figure 3c ). This result was not surprising since previous works indicated that this lipophilic constituent that can be easily extracted with supercritical CO 2 . 21, 61, 62 Ergosterol in ExB represented 72% of total sterols since the extract also included other derivatives such as ergosta-7,22-dienol (18.5 mg/g), fungisterol (15.3 mg/g) and ergosta-5,7-dienol (1.5 mg/g). The supercritical extraction was carried out using steel spheres instead of sand as carrier material to facilitate the subsequent ReB separation for further processing, however, ergosterol yields were only slightly lower than usually obtained in similar extractions using sea sand (8.9 and 11.8%, respectively).
Total phenolic compounds were mostly found in the water extracts. Obtained fractions (ExA and ExC) contained, respectively, 3.0-and 2.5-fold more phenols than initially detected in the mushroom powder. The second water extraction complemented the first one leaving in the last residue a very low amount of these compounds (Figure 3c ). These results were in concordance with previous studies reporting that water achieved higher recoveries of total phenolic compounds in comparison with organic solvents such as methanol. 16 
Biological activities of the obtained fractions
The antioxidant activity of the obtained fractions was evaluated as their ABTS 1• and DPPH • scavenging capacities and as their ferric ion reducing power. Results indicated that those fractions containing high concentrations of proteins, eritadenine and phenolic compounds showed high antioxidant activities (Figure 4) . Their levels were more than double of the initial mushroom powder. ExA and ExC were the fractions with the lowest IC 50 values (respectively, 0.05 and 0.06 mg/mL when using ABTS 1• and 0.15 and 0.17 mg/mL when using DPPH
• ) and the lowest EC 50 for their reducing powder (0.26 and 0.28 mg/mL). According to their TEAC values, the obtained extracts and residues showed higher affinity for the ABTS 1• radical than for DPPH • . The use of different solvents might also influence the obtained results since less polar compounds were extracted when methanol was used to carry out the DPPH
• assay. The shiitake and ExA antioxidant activities were in concordance with previous studies 16, 63 where it was indicated that their antioxidant activities as radical scavengers were mainly due to the phenolic content and ergothioneine.
14 Similarly, the antioxidant activities noticed in the extracts also showed high correlations with their phenolic concentration (with R Cholesterol lowering in serum can be achieved via several mechanisms but mainly by impairing of exogenous cholesterol absorption or inhibiting endogenous cholesterol The initial shiikate powder showed a remarkable HMGCR inhibitory activity acting as pravastatin used as control ( Figure 5 ). ExA showed similar inhibitory activity (98%) than the mushroom indicating that the responsible compounds might be water soluble. However, the inhibitors were not completely separated with a single cold water extraction since ReA and ReB were still able to lower HMGCR activity (respectively, 86 and 80%). Perhaps, to further improve the extraction yield of HMGCR inhibitors serial extractions with cold water could be carried out although this might involve dilution of the other bioactive compounds. Increase of the water temperature for extraction is not encouraged because after heat application, the inhibitory activity of the obtained fractions was drastically reduced to 31 and 24% for, respectively, ExC and ReC, suggesting that the compounds responsible for the inhibition were thermolabile. This indication was also noticed in previous studies. 33 The ExB extract was also able to inhibit 59% of the enzyme activity indicating that perhaps other compounds soluble in supercritical CO 2 (more lipophilic molecules) were also interfering with the HMGCR activity as was also previously noticed by Gil-Ramirez et al. (2013) 64 for SFE extracts obtained from Agaricus bisporus.
The hypotensive activity of the obtained fractions was evaluated as their capacity to inhibit the angiotensin converting enzyme. However, since it was previously reported that certain peptides were responsible compounds a more detailed study was carried out on the two extracts including larger amounts of proteins (ExA and ExC) by dividing them in 3 fractions of different molecular weights. The protein contents of fractions obtained from ExA were higher than those from ExC and within the fractions, lower molecular weight fractions contained less proteins, peptides and other Ncontaining compounds (Table 3) . Fractions <10 kDa showed higher IC 50 than higher MW fractions ranging from 0.45 mg/mL for the MW > 10 kDa fraction from ExA up to 1.63 mg/mL for the MW < 3 kDa fraction from ExC. These values were lower than those reported in similar studies where other mushrooms such as Hypsyzigus marmoreus (6.4 mg/mL) 11 or mycelia extracts from Lactarius camphorates (1.6 mg/mL) 12 were analyzed. A significant correlation between protein content and ACE inhibitory activity was found, however, when IC 50 values were expressed taking into account the amount of proteins detected, fractions with lower molecular weight displayed the largest inhibitory capacity. Therefore, these results were in concordance with previous studies carried out on close related species such as Lentinula polychrous where small peptides were pointed as responsible compounds of their hypotensive properties. 65 
Conclusions
This study showed that bioactive compounds can be differentially extracted from Lentinula edodes fruiting bodies or by-products using a sequential extraction method. Extracts obtained with cold water (ExA) contained high levels of water soluble b-glucans, chitooligosaccharides and other carbohydrates that were pointed as potential responsible for the high HMGCR inhibitory activity showed in this extract. It also contained eritadenine with cholesterol lowering properties, lenthionine that can inhibit platelet aggregation, peptides with ACE inhibitory capacity and antioxidant phenols. Then, the residue after this extraction can be submitted to supercritical CO 2 extraction to obtain a fungal sterolenriched fraction (ExB) with the ability of displacing cholesterol from dietary mixed micelles formed after digestion impairing its absorption. Afterwards, the remaining material can be submitted to hot water extraction yielding an extract (ExC) containing b-glucans with bile acid-binding capacities (able to interfere cholesterol absorption) and similar solubility than lentinan and a residue (ReC) including dietary fibres such as b-glucans and chitins that apparently, according to previous studies, modulate human microbiota reducing the risk of CVDs. Therefore, many biologically active compounds can be separated within different fractions from the same batch of shiitake mushrooms if the described methods are sequentially applied. Then, the obtained fractions will contain higher concentrations of the bioactive compounds than the mushroom itself and they will be transformed into more bioaccesible forms (i.e., dietary fibers will be more easily fermented by colonic microbiota activating hypocholesterolemic mechanisms or absorbed by M cells in the intestine).
